InsidersTradesSigma
Discover the detailed record of transactions filed by SCHIMMEL PAUL, Director. Director active across 2 companies, notably aTYR PHARMA INC. Aggregated, 4 disclosures have been logged. Total volume traded: €3.7m. The latest transaction was filed on 20 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Paul Schimmel is a Board Member at aTYR Pharma Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. His experience in the pharmaceutical sector allows him to provide valuable insights to the board.